Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

about

Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions.

P2860

Q46383705-D5BCC0DD-9E4E-4C5A-87EC-3B67C6D93084

P2860

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

Item

http://www.wikidata.org/entity/Q39121120

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@en

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@nl

type

Item

label

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@en

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@nl

prefLabel

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@en

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@nl

P1476

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

@en

P2093

Anne A Eaton

http://www.w3.org/2001/XMLSchema#string

Catherine E Pesce

http://www.w3.org/2001/XMLSchema#string

Clifford A Hudis

http://www.w3.org/2001/XMLSchema#string

Edi Brogi

http://www.w3.org/2001/XMLSchema#string

Mahmoud El-Tamer

http://www.w3.org/2001/XMLSchema#string

Michelle M Stempel

http://www.w3.org/2001/XMLSchema#string

Sujata M Patil

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

Commercialized multigene predictors of clinical outcome for breast cancer.

The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.

Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancer.

Utilization of Oncotype DX in an Inner City Population: Race or Place?

P2888

s10549-016-4069-4

P304

435-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-016-4069-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P50

James O Murphy

P577

2016-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27928699

http://www.w3.org/2001/XMLSchema#string

P932

5310948

http://www.w3.org/2001/XMLSchema#string

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

about

P2860

P2860

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932